OBJECTIVE: We previously reported preliminary data (N=14) demonstrating a significant and positive relationship between forearm vascular function and neuropsychological performance in individuals with atherosclerotic vascular disease (AVD). The current study was conducted to confirm and extend those findings in a much larger, nonoverlapping sample. METHODS AND RESULTS: Participants were 82 individuals with AVD, with no history of stroke, cardiac surgery, or dementia. Forearm vascular function was measured before and after brachial artery infusion of vasoactive agents (acetylcholine, nitroprusside, verapamil). Neuropsychological functioning was assessed with the Repeatable Battery for the Assessment of Neuropsychological Status. Statistical analysis included multiple regression and partial correlations, controlling for education. Vascular function was significantly and positively associated with neuropsychological performance [R2 change = 0.116, F change (3,74) = 3.72, P = 0.015]. Follow-up analyses indicated that smooth muscle function was the aspect of vascular function most strongly associated with neuropsychological performance. Individual vascular risk factors were not significantly associated with neuropsychological performance when controlling for vascular function. CONCLUSIONS: Better vascular function is significantly associated with better neuropsychological performance in individuals with AVD. It is possible that this relationship exists in healthy elderly individuals as well, although this cannot be determined based on the existing data, because a healthy comparison group was not studied. With additional research, measures of vascular function might be useful in the early identification of individuals who are at greatest risk for developing vascular cognitive impairment.
OBJECTIVE: We previously reported preliminary data (N=14) demonstrating a significant and positive relationship between forearm vascular function and neuropsychological performance in individuals with atherosclerotic vascular disease (AVD). The current study was conducted to confirm and extend those findings in a much larger, nonoverlapping sample. METHODS AND RESULTS:Participants were 82 individuals with AVD, with no history of stroke, cardiac surgery, or dementia. Forearm vascular function was measured before and after brachial artery infusion of vasoactive agents (acetylcholine, nitroprusside, verapamil). Neuropsychological functioning was assessed with the Repeatable Battery for the Assessment of Neuropsychological Status. Statistical analysis included multiple regression and partial correlations, controlling for education. Vascular function was significantly and positively associated with neuropsychological performance [R2 change = 0.116, F change (3,74) = 3.72, P = 0.015]. Follow-up analyses indicated that smooth muscle function was the aspect of vascular function most strongly associated with neuropsychological performance. Individual vascular risk factors were not significantly associated with neuropsychological performance when controlling for vascular function. CONCLUSIONS: Better vascular function is significantly associated with better neuropsychological performance in individuals with AVD. It is possible that this relationship exists in healthy elderly individuals as well, although this cannot be determined based on the existing data, because a healthy comparison group was not studied. With additional research, measures of vascular function might be useful in the early identification of individuals who are at greatest risk for developing vascular cognitive impairment.
Authors: David J Moser; Laura L Boles Ponto; Ivy N Miller; Susan K Schultz; Yusuf Menda; Stephan Arndt; Peggy C Nopoulos Journal: J Clin Exp Neuropsychol Date: 2011-12-13 Impact factor: 2.475
Authors: Daniel E Forman; Ronald A Cohen; Karin F Hoth; Andreana P Haley; Athena Poppas; David J Moser; John Gunstad; Robert H Paul; Angela L Jefferson; David F Tate; Makoto Ono; Nicole Wake; Marie Gerhard-Herman Journal: Artery Res Date: 2008-02-01 Impact factor: 0.597
Authors: Lyndsey E DuBose; Laura L Boles Ponto; David J Moser; Emily Harlynn; Leah Reierson; Gary L Pierce Journal: Hypertension Date: 2018-06-18 Impact factor: 10.190
Authors: Caitlin S Moore; Ivy N Miller; Renee L Andersen; Stephan Arndt; William G Haynes; David J Moser Journal: J Clin Exp Neuropsychol Date: 2010-05-28 Impact factor: 2.475
Authors: Daniel A Nation; Suzi Hong; Amy J Jak; Lisa Delano-Wood; Paul J Mills; Mark W Bondi; Joel E Dimsdale Journal: Med Hypotheses Date: 2011-03-12 Impact factor: 1.538
Authors: John Gunstad; Andreana Benitez; Karin F Hoth; Mary Beth Spitznagel; Jeanne McCaffery; John McGeary; Lynn S Kakos; Athena Poppas; Robert H Paul; Angela L Jefferson; Lawrence H Sweet; Ronald A Cohen Journal: Stroke Date: 2009-07-09 Impact factor: 7.914
Authors: Ashley J Szabo; Michael L Alosco; Lindsay A Miller; John E McGeary; Athena Poppas; Ronald A Cohen; John Gunstad Journal: Psychogeriatrics Date: 2013-10-28 Impact factor: 2.440
Authors: Kelly R Bijanki; Ashley N Stillman; Stephan Arndt; Vincent A Magnotta; Jess G Fiedorowicz; William G Haynes; Joy T Matsui; Hans J Johnson; David J Moser Journal: Int J Geriatr Psychiatry Date: 2013-01-24 Impact factor: 3.485
Authors: David J Moser; Ivy N Miller; Karin F Hoth; Marcelo Correia; Stephan Arndt; William G Haynes Journal: J Int Neuropsychol Soc Date: 2008-07 Impact factor: 2.892
Authors: Kelly Rowe Bijanki; Stephan Arndt; Vincent A Magnotta; Peg Nopoulos; Sergio Paradiso; Joy T Matsui; Hans J Johnson; David J Moser Journal: Psychiatry Res Date: 2013-10-18 Impact factor: 3.222